Home » Topics » BioWorld Science

BioWorld Science
RSS

RSK3 inhibition by gene therapy reduces cardiac dysfunction after myocardial infarction in mice

Nov. 20, 2018

AZD-3229 demonstrates efficacy in preclinical models driven by KIT gene mutations

Nov. 20, 2018

CPI-818 demonstrates promising safety and efficacy in dogs with T-cell lymphoma

Nov. 20, 2018

GeoVax collaborates with Leidos on immunotherapy research program

Nov. 20, 2018

Lupin identifies hSTING agonists for cancer and infections

Nov. 20, 2018

NIH grant supports IBBR's development of antibody therapeutic against HIV-1

Nov. 20, 2018

Ohara Pharmaceutical identifies anticancer agents

Nov. 20, 2018

Phase I data on BLU-5937 support progression to phase II for chronic cough

Nov. 20, 2018

Machavert to use grant award to support RAL GTPase inhibitor development

Nov. 20, 2018

Aviara Pharmaceuticals discloses ITGA4 and LPAM-1 antagonists

Nov. 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...